Citadel Advisors’s Transcat TRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,100
Closed -$227K 14095
2025
Q3
$227K Buy
+3,100
New +$250K ﹤0.01% 10985
2025
Q2
Sell
-1,900
Closed -$141K 15134
2025
Q1
$141K Buy
1,900
+1,700
+850% +$143K ﹤0.01% 10959
2024
Q4
$21.1K Sell
200
-500
-71% -$55.5K ﹤0.01% 13146
2024
Q3
$84.5K Buy
+700
New +$87K ﹤0.01% 11345

Other funds holding TRNS

Citadel Advisors's TRNS Position: Q1 2026 in Review

Citadel Advisors reduced its Transcat (TRNS) stake by 63% in Q1 2026, selling an estimated $4.53M and leaving 37,697 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #5426.

Citadel Advisors first reported a position in TRNS in Q1 2021 and has held it in 18 quarters since. The position peaked at $6.34M in Q2 2025. 159 funds tracked by Wall St. Rank hold TRNS as of Q1 2026.

  • Citadel Advisors held 37,697 shares of Transcat worth $2.77M as of Q1 2026.
  • Citadel Advisors sold 64,384 Transcat shares in Q1 2026, an estimated $4.53M.
  • Transcat made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5426 holding.
  • Citadel Advisors first reported a position in Transcat in Q1 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Transcat position peaked at $6.34M in Q2 2025.
  • 159 funds tracked by Wall St. Rank held Transcat as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.